Search research articles
Contact Us
Filters
Showing results (1-10 of 56) with videos related to
Page
of 6
Sort By:
Pituitary
|
August 21, 2015
The effects of somatostatin analogue therapy on pituitary tumor volume in patients with acromegaly
Annamaria Colao, Renata S Auriemma, Rosario Pivonello
Endocrine Reviews
|
December 3, 2010
Resistance to somatostatin analogs in acromegaly
Annamaria Colao, Renata S Auriemma, Gaetano Lombardi, et al.
Maturitas
|
August 27, 2021
Hyperprolactinemia after menopause: Diagnosis and management
Renata S Auriemma, Rosa Pirchio, Rosario Pivonello, et al.
Muscles, Ligaments and Tendons Journal
|
December 10, 2014
Cushing, acromegaly, GH deficiency and tendons
Mariano Galdiero, Renata S Auriemma, Rosario Pivonello, et al.
Frontiers in Endocrinology
|
October 14, 2022
Metabolic effects of prolactin
Rosa Pirchio, Chiara Graziadio, Annamaria Colao, et al.
Expert Opinion on Drug Safety
|
July 18, 2015
Adverse events associated with somatostatin analogs in acromegaly
Ludovica F S Grasso, Renata S Auriemma, Rosario Pivonello, et al.
Expert Review of Endocrinology & Metabolism
|
July 31, 2018
Somatostatin analogs, cabergoline and pegvisomant: comparing the efficacy of medical treatment for acromegaly
Ludovica F S Grasso, Renata S Auriemma, Rosario Pivonello, et al.
Endocrinology and Metabolism Clinics of North America
|
March 4, 2015
Cabergoline use for pituitary tumors and valvular disorders
Renata S Auriemma, Rosario Pivonello, Lucia Ferreri, et al.
Expert Opinion on Drug Safety
|
February 9, 2016
The safety of treatments for prolactinomas
Renata S Auriemma, Ludovica F S Grasso, Rosario Pivonello, et al.
Reviews in Endocrine & Metabolic Disorders
|
December 29, 2007
Medical consequences of acromegaly: what are the effects of biochemical control?
Annamaria Colao, Renata S Auriemma, Rosario Pivonello, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 56) with videos related to
Sort By:
Page
of 6
Pituitary
|
August 21, 2015
The effects of somatostatin analogue therapy on pituitary tumor volume in patients with acromegaly
Annamaria Colao, Renata S Auriemma, Rosario Pivonello
Endocrine Reviews
|
December 3, 2010
Resistance to somatostatin analogs in acromegaly
Annamaria Colao, Renata S Auriemma, Gaetano Lombardi, et al.
Maturitas
|
August 27, 2021
Hyperprolactinemia after menopause: Diagnosis and management
Renata S Auriemma, Rosa Pirchio, Rosario Pivonello, et al.
Muscles, Ligaments and Tendons Journal
|
December 10, 2014
Cushing, acromegaly, GH deficiency and tendons
Mariano Galdiero, Renata S Auriemma, Rosario Pivonello, et al.
Frontiers in Endocrinology
|
October 14, 2022
Metabolic effects of prolactin
Rosa Pirchio, Chiara Graziadio, Annamaria Colao, et al.
Expert Opinion on Drug Safety
|
July 18, 2015
Adverse events associated with somatostatin analogs in acromegaly
Ludovica F S Grasso, Renata S Auriemma, Rosario Pivonello, et al.
Expert Review of Endocrinology & Metabolism
|
July 31, 2018
Somatostatin analogs, cabergoline and pegvisomant: comparing the efficacy of medical treatment for acromegaly
Ludovica F S Grasso, Renata S Auriemma, Rosario Pivonello, et al.
Endocrinology and Metabolism Clinics of North America
|
March 4, 2015
Cabergoline use for pituitary tumors and valvular disorders
Renata S Auriemma, Rosario Pivonello, Lucia Ferreri, et al.
Expert Opinion on Drug Safety
|
February 9, 2016
The safety of treatments for prolactinomas
Renata S Auriemma, Ludovica F S Grasso, Rosario Pivonello, et al.
Reviews in Endocrine & Metabolic Disorders
|
December 29, 2007
Medical consequences of acromegaly: what are the effects of biochemical control?
Annamaria Colao, Renata S Auriemma, Rosario Pivonello, et al.
Page
of 6